#vizz-eye-drop

[ follow ]
#weight-loss-medications #vision-restoration #dementia #ai-technology #healthcare-innovation
Wearables
fromMail Online
2 weeks ago

AI glasses that can help dementia patients live independently

Revolutionary AI glasses for dementia sufferers can identify objects and provide prompts, enhancing independence and improving quality of life.
fromIndependent
3 weeks ago

Luke O'Neill: Weight-loss drugs have been linked to sudden blindness, so how worried should you be?

The weight loss jabs Ozempic, Mounjaro and Wegovy - a type of medicine containing semaglutide - are increasingly being seen as a medical wonder of the age. They bring great benefits to people with diabetes and obesity.
Medicine
Medicine
fromIndependent
3 weeks ago

Weight-loss jab Wegovy has 'highest risk of rare eye stroke', study finds

Wegovy carries nearly five times higher risk of eye stroke and sudden sight loss compared to Ozempic, with men facing three times greater risk than women.
Public health
fromEngadget
2 months ago

Eyebot promises an accurate eye test in a couple of minutes

Eyebot's kiosk performs quick, walk-up eye tests in about three minutes, creating 3D retinal models and filing prescriptions by email to improve accessibility.
Gadgets
fromFuturism
2 months ago

Instant Bifocals: New Glasses Can Change Their Prescription on the Fly Depending on What You're Looking At

IXI developed eyeglasses with liquid-crystal dynamic lenses that automatically adjust focus using eye-tracking and infrared sensors.
Medicine
fromwww.bbc.com
2 months ago

Revolutionary eye injection saved my sight, says first-ever patient

A pioneering low-cost treatment at Moorfields restored sight and prevented blindness in most pilot-study patients with hypotony.
from24/7 Wall St.
2 months ago

Is Apellis Pharmaceuticals' FDA Win Just the Beginning?

EMPAVELI is the first and only approved treatment for C3G and IC-MPGN across pediatric patients 12+, adults, and post-transplant recurrence. That's roughly 5,000 patients in the U.S., with EMPAVELI holding exclusive approval for about two-thirds. Add the European CHMP positive opinion in December 2025, and you have a rare disease franchise with global expansion potential and pricing power that typically commands gross margins north of 90%.
Medicine
Medicine
fromenglish.elpais.com
1 month ago

Brain implant restores vision to a man blinded by an optic nerve injury

A 4x4 mm microneedle implant in the visual cortex restored partial vision in a NAION patient, enabling light perception, movement detection, object identification, and reading large characters.
[ Load more ]